A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance

Transl Cancer Res. 2023 Oct 31;12(10):2442-2447. doi: 10.21037/tcr-23-1247. Epub 2023 Oct 10.

Authors

Anya K Sondhi¹, Carla Barrientos Risso^{1

2}, Justin Taylor¹

Affiliations

¹ Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
² Department of Medicine, Ponce Health Sciences University, Ponce, PR, USA.

No abstract available

Keywords: CD19 CAR T-cell; Chimeric antigen receptor (CAR); lymphoma; resistance.

Publication types

Editorial
Comment

Grants and funding

K08 CA230319/CA/NCI NIH HHS/United States